Literature DB >> 11027253

Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs.

E Carboni1, A Silvagni, M T Rolando, G Di Chiara.   

Abstract

Drugs of abuse preferentially increase dopamine transmission in the shell of the nucleus accumbens. This area is considered as a transition between the striatum and the extended amygdala a complex neural system that includes the central amygdala and the bed nucleus of stria terminalis, areas that, like the nucleus accumbens shell, are heavily innervated by mesolimbic dopamine neurons originating in the ventral tegmental area. Given the anatomical and neurochemical relationships and similarities with the nucleus accumbens shell it was of interest to investigate whether the dopamine transmission of the bed nucleus of stria terminalis shares with the accumbens shell the peculiar responsiveness to drugs of abuse. To this end we studied by microdialysis with concentric probes, the effect of drugs of abuse on extracellular dopamine in the bed nucleus of stria terminalis. We report that morphine, nicotine, cocaine, ethanol, and the selective dopamine uptake inhibitor GBR 12909 increase effectively and dose dependently extracellular dopamine in the bed nucleus of stria terminalis. These results indicate that the bed nucleus of stria terminalis shares with the nucleus accumbens shell a peculiar sensitivity to the dopamine stimulant actions of drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027253      PMCID: PMC6772858     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

1.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

2.  In vivo effects of the anatoxin-a on striatal dopamine release.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

Review 3.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

Review 4.  Cortisol secretion patterns in addiction and addiction risk.

Authors:  William R Lovallo
Journal:  Int J Psychophysiol       Date:  2006-01-24       Impact factor: 2.997

5.  Chronic ethanol exposure leads to divergent control of dopaminergic synapses in distinct target regions.

Authors:  Julie C Healey; Danny G Winder; Thomas L Kash
Journal:  Alcohol       Date:  2008-03-20       Impact factor: 2.405

6.  D1 dopamine receptor-mediated LTP at GABA synapses encodes motivation to self-administer cocaine in rats.

Authors:  Michal Krawczyk; Xenos Mason; Julian DeBacker; Robyn Sharma; Catherine P Normandeau; Emily R Hawken; Cynthia Di Prospero; Cindy Chiang; Audrey Martinez; Andrea A Jones; Évelyne Doudnikoff; Stephanie Caille; Erwan Bézard; François Georges; Éric C Dumont
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

7.  Illuminating the opponent process: cocaine effects on habenulomesencephalic circuitry.

Authors:  Patrick E Rothwell; Stephan Lammel
Journal:  J Neurosci       Date:  2013-08-28       Impact factor: 6.167

8.  A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis.

Authors:  Yuval Silberman; Robert T Matthews; Danny G Winder
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

Review 9.  Heterogeneity of reward mechanisms.

Authors:  A Lajtha; H Sershen
Journal:  Neurochem Res       Date:  2009-12-12       Impact factor: 3.996

Review 10.  Ethanol effects on N-methyl-D-aspartate receptors in the bed nucleus of the stria terminalis.

Authors:  Tiffany A Wills; Danny G Winder
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.